Clinical trial
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute…
NCT00004494 · Stony Brook University, Other · Completed
Key facts
| NCT number | NCT00004494 |
|---|---|
| Title | Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis |
| Lead sponsor | Stony Brook University, Other |
| Collaborators | State University of New York FDA Office of Orphan Products Development U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sepsis, Respiratory Distress Syndrome, Adult |
| Intervention type | Drug |
| Interventions | vasoactive intestinal peptide |
| Enrollment | 18 |
| Start date | Sep 1, 1998 |
| First posted | Oct 19, 1999 |
| Last update posted | May 4, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: